NEW YORK (GenomeWeb News) — Caliper Life Sciences today said first-quarter revenues increased 27 percent as R&D spending grew 29 percent to contribute to a 120-percent surge in net losses.
 
Separately today, the company said it has licensed microfluidics IP from Monogram.
 
Total receipts for the three months ended March 31 increased to $28.4 million from $22.3 million year over year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.